Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development
Céline Dutruel(German Cancer Research Center), Peter Schmezer(German Cancer Research Center), Christoph Plass(German Cancer Research Center), P. Sivaramakrishna Rachakonda(German Cancer Research Center), Thomas M. Kaffenberger(VA Pittsburgh Healthcare System), Ilse Rooman(Vrije Universiteit Brussel), Michael Rehli(University Hospital Regensburg), Dieter Weichenhan(German Cancer Research Center), Huaping Xie(Tongji Hospital), Manuela Zucknick(German Cancer Research Center), Peter Schirmacher(Heidelberg University), Andrea S. Bauer(Boston Children's Hospital), Changki Hong(UCSF Helen Diller Family Comprehensive Cancer Center), Odilia Popanda(German Cancer Research Center), J Costello(University of California, San Francisco), Rajiv Kumar(Army Hospital Research and Referral), Julia Werner(University Hospital Heidelberg), N. Giese(Heidelberg University), Lea Geiselhart(German Cancer Research Center), Frank Bergmann(Heidelberg University), Jörg D. Hoheisel(German Cancer Research Center)
Cited by 38
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Complete genome sequence and comparative analysis of the metabolically versatile <i>Pseudomonas putida</i> KT2440
|Environmental Microbiology|2002|1.4k